FORT WORTH, Texas, May 7, 2015 /PRNewswire/ --
The global ophthalmology glaucoma surgery device market was valued at $210.3 million in 2014 and is estimated to grow to $314.3 million by 2019, at a CAGR of 8.4% during the period under consideration.
Browse through the TOC of Glaucoma Surgery Devices Market for an analysis of industry trends and segments, with the help of various tables and figures.
Early buyers will receive 10% customization on this report.
Glaucoma is the second most common cause of blindness worldwide, and the leading cause of bilateral, irreversible blindness. It is characterized by the relatively high Intraocular Pressure (IOP) as a result of impaired drainage of a fluid, known as aqueous humor, from the eye. Currently, the approved treatments for glaucoma include a pharmaceutical drug, glaucoma laser therapies, and surgical procedures. It is estimated that by 2020, 11 million individuals will be blind due to glaucoma and around 10% of the people suffering from eye disorders will experience loss of vision in spite of proper treatment.
The increasing prevalence of eye-related disorders, such as macular degeneration and diabetic retinopathy; the aging population worldwide; and the rising government initiatives towards healthcare infrastructure in developing countries are among the key driving factors for the global ophthalmic ophthalmology glaucoma surgery device market.
The key players in the global ophthalmology glaucoma surgery device market are Abbott Laboratories (U.S.), Alcon, Inc. (Switzerland), Carl Zeiss Meditec AG (Germany), Nidek Co., Ltd. (U.S.), Lumenis Ltd. (Israel), Ellex Medical Lasers Ltd. (Australia), and Iridex Corporation (U.S.).
This market has been segmented and forecast on the basis of type and end-user. The types include Glaucoma Drainage Devices (GDD), glaucoma implants and stents, glaucoma lasers, and glaucoma systems; while the end-users are categorized into private eye clinics, and hospitals, among others. The global ophthalmology glaucoma surgery device market has been further segmented and forecast on the basis of geography such as North America, Europe, Asia, and Rest of the World (RoW).
The North America Ophthalmology Glaucoma Surgery Devices Market is estimated to grow at a CAGR of 7.8% from 2014 to 2019. Increasing aging population, increasing incidences of ocular disorders, and rising incidences of obesity and diabetes are the major factors driving the growth of this market.
MicroMarket Monitor produces exclusive market research reports, based on real-time data to provide better understanding of the dynamic market conditions of the Healthcare industry. The reports offer in-depth and complete analysis of the regional and country level marketplaces. The research reports for Healthcare industry are updated on quarterly basis and are easily available for purchase through annual subscriptions.
About MicroMarket Monitor:
MicroMarket Monitor identifies and attends to various unmet needs of different industrial verticals, which include value chain impact analysis. The company publishes about 12000 Market Research Reports on various Micro Markets across the world. The graphical nature and multidimensional analysis of these reports provide advanced Business Intelligence Tools to the clients in that particular target market.
Mr. Chandrasekhar K.
5601 Bridge Street
Fort Worth, TX 76112